Androgen insensitivity syndrome - Clinical trials 

  • Overview
  • Clinical trials

Clinical trials for Androgen insensitivity syndrome

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Androgen insensitivity syndrome. For all clinical trials, go to clinical trials search

This list shows clinical trials for Androgen insensitivity syndrome

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Androgen insensitivity syndrome
Title Recruitment status Location
ACtive Treatment for Idiopathic AdolescenT Scoliosis: a feasibility study Recruiting United Kingdom
A SINGLE CENTRE, GAMMA SCINTIGRAPHY STUDY IN ASTHMATIC PATIENTS TO COMPARE PULMONARY DEPOSITION AND PHARMACOKINETICS OF ALBUTEROL INHALATION SOLUTION (AIS) DELIVERED VIA eFLOW NEBULISER AND SALBUTAMOL NEBULISER SOLUTION VIA LC PLUS NEBULISER Not Recruiting United Kingdom
Safety and Pharmacokinetics of MCI-186 in Subjects With Acute Ischemic Stroke Not recruiting United Kingdom
Scoliosis correction force measurement study Not recruiting United Kingdom
A Phase III, Double-Blind, Placebo Controlled, Parallel Group, International, Multicenter Study of 12 Weeks Treatment with Trafermin 0.01% Spray in Patients with Diabetic Foot Ulcer of Neuropathic Origin. - The TRAfermin in Neuropathic diabetic foot ulcer Study - northern Europe. The TRANS-North study Not Recruiting United Kingdom
Clinical study compering Trafermin 0.01% spray and placebo in patients with diabetic foot ulcer of neuropathic origin. Authorised United Kingdom
Clinical study comparing Trafermin 0.01% spray and placebo in patients with diabetic foot ulcer. Authorised United Kingdom
Clinical study comparing Trafermin 0.01% spray and placebo in patients with diabetic foot ulcer of neuropathic origin. Authorised United Kingdom
Clinical study comparing Trafermin 0.01% spray and placebo in patients with diabetic foot ulcer of neuropathic origin. Authorised United Kingdom
Clinical study comparing Trafermin 0.01% spray and placebo in patients with diabetic foot ulcer of neuropathic origin. Authorised United Kingdom